Skip to main content
SpringerLink
Log in

Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Bone marrow biopsy (BMB) has aroused growing interest as a possible aid in the diagnostic and prognostic evaluation of myelodysplastic syndromes (MDS). Previous reports have pointed out that MDS patients with blastic aggregates or severe bone marrow (BM) fibrosis are characterized by a worse clinical outcome. BMBs of 106 MDS patients were retrospectively reviewed, and relationships among the different histological parameters as well as clinicopathological correlations were looked for. Three patterns of BM blastic infiltration (“diffuse,” “cluster,” and “large”) were recognized. Overt leukemic transformation and overall survival were selected as prognostic end points. BM infiltration was “diffuse” in 18, “cluster” in 48, and “large” in 40 cases. RAEB-t patients accounted for about half of the “large” cases, and none had a “diffuse” pattern (p<0.01). Nineteen patients showed extensive BM fibrosis; most of them were characterized by “cluster” blastic infiltration and megakaryocyte hyperplasia. Leukemic transformation occurred in 67% of “large” cases (p<0.001) and in none of the “cluster” cases with severe BM fibrosis (p<0.01); however, survival was equally poor in these two groups because of early leukemic transformation (large cases) and BM failure (cluster cases). The FAB classification did not significantly correlate with prognosis. Patients with “cluster” BM infiltration and severe fibrosis can be regarded as a true separate MDS subset characterized by unique clinicopathological and prognostic features. Because of the subacute clinical behavior of most cases, and the poor performance status of many elderly patients, there is still controversy as to the best therapeutic approach in MDS. Histological analysis allowed two groups of MDS patients to be identified, both characterized by poor life expectancy, who could benefit from early aggressive chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benitez J, Carbonell F, Sanchez Fayos J, Heimpel H (1985) Karyotypic evolution in patients with MDS. Cancer Genet Cytogenet 16: 156–167

    Google Scholar 

  2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukemias. Br J Haematol 33: 451–454

    Google Scholar 

  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of myelodysplastic syndromes. Br J Haematol 51: 189–199

    Google Scholar 

  4. Beris P (1989) Primary clonal myelodysplastic syndromes. Semin Hematol 26: 216–233

    Google Scholar 

  5. Cassano E, Giordano M, Riccardi A, Cocci A, Cazzola M (1990) Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system. Haematologica (Pavia) 75: 141–145

    Google Scholar 

  6. Coiffier B, Adeleine P, Viala JJ, Bryon PA, Fiere D, Gentilhomme O, Vuvan H (1983) Dysmyelopoietic syndromes: a search for prognostic factors. Cancer 52: 83–90

    Google Scholar 

  7. Coiffier B, Adeleine P, Gentilhomme O, Felman P, Treille-Ritouet D, Bryon PA (1987) Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients. Cancer 60: 3029–3032

    Google Scholar 

  8. Fenaux P, Morel P, Rose C, Lai JL, Jouet JP, Bauters F (1991) Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Br J Haematol 77: 497–501

    Google Scholar 

  9. Garcia S, Sanz MA, Amigo V, Colomina P, Carrera MD, Lorenzo JI, Sanz GF (1988) Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases. Am J Hematol 27: 163–168

    Google Scholar 

  10. Hamblin TJ, Oscier DG (1987) The myelodysplastic syndrome: a practical guide. Hematol Oncol 5: 19–34

    Google Scholar 

  11. Horiike S, Taniwaki M, Misawa S, Abe T (1988) Chromosome abnormality as end karyotypic evolution in 83 patients with MDS and predictive value for prognosis. Cancer 62: 1129–1138

    Google Scholar 

  12. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau M, Rowley JD (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67: 1765–1772

    Google Scholar 

  13. Kitagawa M, Kamiyama R, Takemura T, Kasuga T (1989) Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Archiv B 57: 47–53

    Google Scholar 

  14. Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D (1991) Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol 78: 161–166

    Google Scholar 

  15. Lambertenghi-Deliliers G, Soligo D, Annaloro C, Pozzoli E, Riva A (1992) Bone marrow biopsy in RAEB and RAEB-t myelodysplastic syndromes. In: Schmalzl F, Mufti GJ (eds) Myelodysplastic syndromes. Springer, Berlin Heidelberg New York, pp 67–73

    Google Scholar 

  16. Mangi MH, Salisbury JR, Mufti GJ (1991) Abnormal localization of immature precursors (ALIP) in the bone marrow of myelodysplastic syndromes: current state of knowledge and future directions. Leukemia Res 7: 627–639

    Google Scholar 

  17. Manoharan A, Horsley R, Pitney WR (1979) The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol 43: 185–190

    Google Scholar 

  18. Mertelsmann R, Tvzi Thaler H, To L, Gee TS, McKenzie S, Schauer P, Friedman A, Arlin Z, Cirrincione C, Clarkson B (1980) Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood 56: 773–781

    Google Scholar 

  19. Ohyashiki K, Sasao I, Ohyashiki JH, Murakami T, Iwabuchi A, Tauchi T, Saito M, Nakazawa S, Serizaw H, Ebihara Y, Toyama K (1990) Clinical and cytogenetic caracteristics of myelodysplastic syndromes developing myelofibrosis. Cancer 68: 178–183

    Google Scholar 

  20. Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinicomorphological study of 10 cases. Br J Haematol 71: 499–504

    Google Scholar 

  21. Ríos A, Canizo MC, Sanz MA, Vallespi P, Sanz G, Torrabadella M, Gomis F, Ruiz C, San Miguel JF (1990) Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br J Haematol 75: 26–33

    Google Scholar 

  22. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74: 395–408

    Google Scholar 

  23. Sultan C, Sigaux F, Imbert M, Reyes F (1981) Acute myelodysplasia with myelofibrosis: a report of eight cases. Br J Haematol 49: 11–16

    Google Scholar 

  24. Thiele J, Quitman H, Wagner S, Fischer R (1991) Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens. J Clin Pathol 44: 300–305

    Google Scholar 

  25. Tricot G, De Wolf-Peeters C, Vlientinck R, Verwilghen RL (1984) Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol 58: 217–225

    Google Scholar 

  26. Tricot G, Vlietinck R, Boogaerts MA (1985) Prognostic factors in the MDS. Importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol 60: 19–32

    Google Scholar 

  27. Verhoef GEG, De Wolf-Peeters C, Ferrant A, Deprez S, Meeus P, Stul M, Zacheé P, Cassiman JJ, Van den Berghe H, Boogaerts MA (1991) Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol 63: 235–241

    Google Scholar 

  28. Verhoef GEG, De Wolf-Peeters C, Van de Broeck J, Zacchée P, Boogaerts MA (1991) Update on the prognostic value of bone marrow histology in patients with primary myelodysplastic syndromes. Blood 78 [Suppl 1]: 332a

    Google Scholar 

  29. Watts EJ, Majer RV, Green PJ, Mavor WO (1991) Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone. Br J Haematol 78: 120–122

    Google Scholar 

  30. Weisdorf DJ, Oken MM, Johnson GJ, Rydell RE (1983) Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukemia. Br J Haematol 55: 691–700

    Google Scholar 

  31. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell MM (1986) Refined chromosome analysis as an independent prognostic indicator in de novo MDS. Blood 67: 1721–1730

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Scienze Mediche, University of Milan, Fondazione Matarelli, Milan, Italy

    G. Lambertenghi-Deliliers, C. Annaloro, A. Oriani, D. Soligo, E. Pozzoli & E. E. Polli

Authors
  1. G. Lambertenghi-Deliliers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Annaloro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Oriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Soligo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Pozzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. E. Polli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lambertenghi-Deliliers, G., Annaloro, C., Oriani, A. et al. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Ann Hematol 66, 85–91 (1993). https://doi.org/10.1007/BF01695890

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695890

Key words

Search

Navigation